Oslo, 26 August 2021
 
Circa Group AS (Euronext Growth Oslo: CIRCA) today announced its second quarter
2021 results. Please find attached to this press release the quarterly report
and presentation. A webinar will be held at 08:30 CEST today, register your
interest by sending an e-mail to info@circagroup.no.

Despite COVID-19 restrictions, the ReSoluteTM project continues to progress close
to schedule. Negotiations with the site owner continue and initial site work is
planned to start end third quarter 2021. Measures have been taken to minimise
effects of raw material and shipping price increases for machinery and equipment
orders, and an update on cost budget implications will be given will be given
within the Q3 financial reporting period.

Discussions on sales agreements remain positive with all partners and the level
of enquiries for the biobased solvent CyreneTM remains strong. Traditional
fossil-based and toxic competitors to CyreneTM have seen large price increases
recently and there is some hesitancy in the market to commit to large offtake
volumes with the currently volatile pricing levels. Circa is also taking a
proactive step to engage with a limited number of global brand owners where
there are synergies between Circa's product offering and the companies'
sustainability targets.

"Circa continues to move forward on all fronts of the business, despite COVID-19
headwinds. We see strong regional and EU support for the ReSoluteTM project and
high interest in our biochemical products from customers and distribution
partners. During the quarter, we have also been very pleased to advise Tone
Leivestad has been appointed as our new CFO. Tone will be based in Oslo, Norway,
and start on 1 September", says Tony Duncan, CEO of Circa Group.

Circa had no significant sales in the quarter. No significant sales are expected
prior to commissioning and start-up of the ReSoluteTM plant in the first quarter
of 2023. As of 30 June 2021, Circa had cash and cash equivalents of EUR 49.7
million.

About Circa
Established in 2006, Circa Group converts waste, non-food biomass into advanced
bio-based chemicals with its proprietary FuracellTM process. Its developing
product portfolio includes flavours, biopolymers, and bio-solvents including
CyreneTM, an alternative to traditional polar aprotic solvents, which is produced
in one step from platform biomolecule Levoglucosenone. By creating novel and
replacement chemicals from renewable feedstocks, Circa is both extracting value
from non-food, waste biomass, and addressing growing market demands for
bio-based alternatives that are driving a more sustainable economy. 
www.circa-group.com

Media Contact 					Company Contact
Kathryn Sheridan					Tony Duncan
Sustainability Consult				CEO - Circa Group Ltd
ks@sustainabilityconsult.com			tony.duncan@circa-group.com 
+32 496 116198					
www.sustainabilityconsult.com			www.circa-group.com